The Genetics Coordinating Core (GCC) at Columbia has been in existence for two years. The Core was initially supported through a supplement from the National Institute on Aging (NIA), Alzheimer's Disease Research Centers (ADRC/ADC) Program, with the goal of coordinating the collection of families in which two or more individuals have Alzheimer's disease from the collaborating centers. The overall program is entitled the NIA-Genetics Initiative for Late-Onset Alzheimer's Disease (NIA-LOAD Study). The collection of these families was designed using a multi-center approach that originally included 10 ADCs and was later expanded to include 18 centers for which Columbia University's ADRC has been the Coordinating Center. In addition, ADCs not included in the NIA Genetics Initiative have been able to submit families for consideration. Over the past year and a half, the GCC at the Columbia ADRC has developed, circulated and refined a procedures manual, reviewed and approved over 500 families for inclusion in the National Cell Repository for Alzheimer's Disease (NCRAD), specified the type of data to be collected and transmitted to NCRAD and have developed standardized format to collect age-at-onset, assess cognitive performance, collect biomarkers and autopsy material. The goals for the GCC over the next 5 years are to: expand the current collection of families by identifying and examining new families meeting NIA-LOAD criteria for inclusion, assist the participating centers to identify newly affected family members within existing families, develop and implement follow-up procedures, including autopsy, for the participating families and family members, facilitate and coordinate the recruitment of up to 1,000 individuals unrelated to the participating families without dementia to form """"""""control"""""""" group similar in age, sex and ethnic background for association analyses by using similar methods to identify potential individuals, and develop and implement methods for standardized assessment of a series of quantitative traits for application in the NIA-LOAD study.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG008702-16
Application #
6932713
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J4))
Project Start
2005-06-01
Project End
2010-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
16
Fiscal Year
2005
Total Cost
$206,000
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Winawer, Melodie R; Griffin, Nicole G; Samanamud, Jorge et al. (2018) Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol 83:1133-1146
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Qureshi, Yasir H; Patel, Vivek M; Berman, Diego E et al. (2018) An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect. Mol Cell Biol 38:
Reitz, Christiane (2018) Retromer Dysfunction and Neurodegenerative Disease. Curr Genomics 19:279-288
Tariciotti, Leonardo; Casadei, Matthew; Honig, Lawrence S et al. (2018) Clinical Experience with Cerebrospinal Fluid A?42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia. J Alzheimers Dis 65:1417-1425
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Masucci, Michael D; Lister, Amanda; Corcoran, Cheryl M et al. (2018) Motor Dysfunction as a Risk Factor for Conversion to Psychosis Independent of Medication Use in a Psychosis-Risk Cohort. J Nerv Ment Dis 206:356-361

Showing the most recent 10 out of 640 publications